Orange Book product · Generic (ANDA)
VINCRISTINE SULFATE
VINCRISTINE SULFATE
At a glance
Apr 11, 1988
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 11, 1988
38 yr 9 mo ago
Today
Pharmaceutical detail
Active ingredient
VINCRISTINE SULFATE
Strength
5MG/VIAL
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 071561
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of VINCRISTINE SULFATE
- 2012MARQIBO KITBrand (NDA)
NDA 202497 · ACROTECH
- —ONCOVINBrand (NDA)
NDA 014103 · LILLY
- 2003VINCRISTINE SULFATEGeneric (ANDA)
ANDA 076401 · FRESENIUS KABI USA
- 2002VINCRISTINE SULFATEGeneric (ANDA)
ANDA 076296 · FRESENIUS KABI USA
- 1999VINCRISTINE SULFATE PFSGeneric (ANDA)
ANDA 075493 · TEVA PHARMS USA
- 1988VINCREXGeneric (ANDA)
ANDA 070867 · BRISTOL MYERS SQUIBB
- 1988VINCRISTINE SULFATE PFSGeneric (ANDA)
ANDA 071484 · HOSPIRA
- 1988VINCRISTINE SULFATEGeneric (ANDA)
ANDA 071559 · HOSPIRA
- 1988VINCRISTINE SULFATEGeneric (ANDA)
ANDA 071560 · HOSPIRA
- 1987VINCASAR PFSGeneric (ANDA)
ANDA 071426 · TEVA PARENTERAL
- 1987VINCRISTINE SULFATEGeneric (ANDA)
ANDA 070873 · ABIC
- 1986VINCRISTINE SULFATEGeneric (ANDA)
ANDA 070411 · ABRAXIS PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
